The clinic offers a full preventive health scan in about an hour: a connected view of a member's skin, heart, blood, and metabolic health, with the results explained by a clinician before they leave. The scan is priced at $499, and the company says customers can use health savings and flexible spending account funds to pay for it.
More than 25,000 New Yorkers joined a waitlist ahead of launch, according to the company. Neko says more than 100,000 members have already been scanned across Sweden and the United Kingdom, where the company started operations.
Prevention, not treatment
Nilsonne and Ek founded Neko Health to shift the focus of medicine from treating disease after it develops to helping people understand and act on their health earlier. The company says 75 percent of members book and prepay their next scan at the end of their first appointment, and 80 percent go on to book a third after their second — figures it presents as evidence of sustained demand.
The American launch lands in a health system where roughly six in ten adults live with a chronic disease, about four in ten live with two or more, and nearly 90 percent of national health spending goes toward people managing chronic and mental health conditions. Research cited by Neko notes that up to 80 percent of premature heart disease and stroke is preventable.
“Hjalmar and I have talked about bringing Neko to America since the earliest days of the company because if you want to change healthcare at scale, the U.S. has to be part of that ambition,” said Ek. “New York is the starting point. New Yorkers place an incredible value on their time and have exceptionally high expectations for how they spend it. This city doesn’t settle for good enough, and neither do we.”
A billion-dollar bet on preventive care
The U.S. expansion follows a $700 million funding round that brought the company's total capital raised to nearly $1 billion. The move turns a heavily funded European health-scanning operation into a direct test of American demand for preventive, consumer-grade healthcare.
Ek, who became Spotify's executive chairman on January 1, 2026 after stepping down as chief executive, now leads a second founder-driven business — one that must earn trust with medical data and clinical follow-up as well as a polished consumer experience.
Some industry watchers note that waitlists measure interest rather than paid demand, and Neko has said follow-up treatment remains with patients' own clinicians. The company's U.S. terms leave medical follow-up to each member's personal doctor, keeping the scan itself focused on detection and early awareness.
New York is only the start
Neko describes the SoHo clinic as the first of many planned across New York City and nationwide, positioning the United States as the centerpiece of its growth ambitions. Booking is now open at the company's Manhattan location, and the company is framing the American rollout as the decisive test of whether its model can scale preventive care beyond Europe.
